首页|LCN2通过P38 MAPK-PGC1α-PPARγ通路抑制脂多糖介导的小鼠BV2小胶质细胞M1极化

LCN2通过P38 MAPK-PGC1α-PPARγ通路抑制脂多糖介导的小鼠BV2小胶质细胞M1极化

扫码查看
目的:探究脂质运载蛋白2(LCN2)在脂多糖(LPS)诱导的小鼠小胶质细胞BV2极化中的作用,并基于P38丝裂原活化蛋白激酶(MAPK)通路探究其可能机制。方法:体外培养小鼠BV2小胶质细胞,利用LPS处理小鼠BV2小胶质细胞诱导M1极化,构建炎症模型,并通过短发夹RNA(shRNA)及外源性LCN2蛋白沉默或过表达BV2细胞中LCN2的表达。分为对照组、LPS(100 µg/L)组、LPS+sh-NC组、LPS+sh-LCN2和LPS+LCN2(1 mg/L)组。流式细胞术检测CD16/32+和CD206+T细胞数量;Western blot和RT-qPCR检测P38 MAPK、过氧化物酶体增殖物激活受体γ(PPARγ)和PPARγ辅激活因子1α(PGC-1α)的蛋白及基因表达,阐明LCN2对LPS诱导的BV2细胞极化及P38 MAPK通路的影响。进一步利用P38 MAPK通路抑制剂SB203580处理LPS或LCN2诱导的细胞,分为对照组、LPS组、LPS+LCN2(1 mg/L)组、LPS+SB203580(50 nmol/L)组和LPS+LCN2+SB203580组。ELISA检测炎症因子表达,Western blot检测M1/M2标志蛋白的表达,Western blot和RT-qPCR检测P38 MAPK通路蛋白及基因表达。结果:LPS显著促进BV2细胞中LCN2的表达(P<0。05),并诱导M1极化(P<0。01)。沉默LCN2后抑制LPS诱导的BV2细胞中LCN2的表达及M2极化(P<0。01),促进M1极化(P<0。01),并抑制P38 MAPK-PGC-1α-PPARγ通路的激活(P<0。05)。外源性添加LCN2表现出相反的作用,即促进LPS诱导的细胞向M2极化(P<0。01),并促进P38 MAPK通路的激活(P<0。05)。通路抑制剂的使用进一步证实LCN2可通过P38 MAPK通路参与调控LPS诱导的小胶质细胞极化。结论:LCN2通过激活P38 MAPK通路抑制LPS介导的小鼠BV2小胶质细胞M1极化,促进其M2极化,在神经炎症反应中发挥保护作用。
LCN2 inhibits lipopolysaccharide-mediated M1 polarization of mouse BV2 microglia through P38 MAPK-PGC1α-PPARγ pathway
AIM:To investigate the role of lipocalin 2(LCN2)in lipopolysaccharide(LPS)-induced microg-lia polarization in mice and to elucidate the potential mechanisms involving the P38 mitogen-activated protein kinase(MAPK)pathway.METHODS:BV2 microglia were treated with LPS to induce M1 polarization,and short hairpin RNA(shRNA)and exogenous LCN2 protein were used to silence or overexpress LCN2 in BV2 cells.BV2 microglia were cul-tured in vitro and divided into the following groups:control,LPS(100 µg/L),LPS+sh-NC,LPS+sh-LCN2,and LPS+LCN2(1 mg/L).Flow cytometry was used to detect the number of CD16/32+and CD206+T cells.Western blot and RT-qP-CR were employed to measure the protein and mRNA levels of P38 MAPK,PGC-1α,and PPARγ to assess the effects of LCN2 on LPS-induced BV2 cell polarization and the P38 MAPK pathway.Additionally,the P38 MAPK pathway inhibitor SB203580 was used to treat LPS or LCN2-induced cells.The cells were categorized into control,LPS,LPS+LCN2(1 mg/L),LPS+SB203580(50 nmol/L),and LPS+LCN2+SB203580 groups.ELISA was used to measure inflammatory factor levels,Western blot was used to detect M1/M2 marker proteins,and Western blot and RT-qPCR were used to analyze pro-tein and mRNA expressions in the P38 MAPK pathway.RESULTS:LPS significantly increased LCN2 expression in BV2 cells(P<0.05)and induced M1 polarization(P<0.01).Silencing LCN2 reduced LCN2 expression and M2 polarization in LPS-induced BV2 cells(P<0.01),increased M1 polarization(P<0.01),and inhibited activation of the P38 MAPK-PGC-1α-PPARγ pathway(P<0.05).Conversely,exogenous addition of LCN2 promoted M2 polarization in LPS-induced BV2 cells and activated the P38 MAPK pathway(P<0.05).The use of a P38 MAPK pathway inhibitor further confirmed that LCN2 modulates LPS-induced microglia polarization through the P38 MAPK pathway.CONCLUSION:LCN2 inhibits LPS-mediated M1 polarization of BV2 microglia by activating the P38 MAPK pathway,thereby playing a protective role in neuroinflammatory responses.

lipocalin 2lipopolysaccharidemicroglianeuroinflammationP38 MAPK signaling pathway

冯怡墨、赖军、林波、潘金玉、周扬浩、杜寒剑

展开 >

重庆大学附属人民医院,重庆市人民医院神经外科,重庆 401147

脂质运载蛋白2 脂多糖 小胶质细胞 神经炎症 P38 MAPK信号通路

2024

中国病理生理杂志
中国病理生理学会

中国病理生理杂志

CSTPCD北大核心
影响因子:1.065
ISSN:1000-4718
年,卷(期):2024.40(12)